Navegar por autor "Gómez-Reino Carnota, Juan Jesús"

4.2-year results: Long-term efficacy of tocilizumab treatment for RA

2011- Gómez-Reino Carnota, Juan Jesús

A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

2012- Gómez-Reino Carnota, Juan Jesús

Actualizacion 2014 del Documento de Consenso de la Sociedad Espanola de Reumatologia sobre el uso de terapias biologicas en la artritis reumatoide

2015- Gómez-Reino Carnota, Juan Jesús

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain

2021- POMBO SUAREZ, MANUEL ENRIQUE; Maneiro Fernández, José Ramón; Gómez-Reino Carnota, Juan Jesús

Adipokines and osteoarthritis: Novel molecules involved in the pathogenesis and progression of disease

2011- Conde Aranda, Javier; Scotece, Morena; Gómez, Rodolfo; López López, Verónica; Gómez-Reino Carnota, Juan Jesús; [et al.]

Adipokines as biomarkers of rheumatic diseases

2012- Gómez-Reino Carnota, Juan Jesús; Lago Paz, Francisca; Scotece, Morena; Gualillo ., Oreste; Conde Aranda, Javier; [et al.]

Adipokines as drug targets in joint and bone disease

2014- Gómez-Reino Carnota, Juan Jesús; Lago Paz, Francisca; Scotece, Morena; Gualillo, Oreste; Conde Aranda, Javier; [et al.]

ADIPOKINES INDUCE INFLAMMATORY MEDIATORS IN CD4+T CELLS AND MODULATE THE CROSS TALK BETWEEN CD4+T LYMPHOCYTES AND CHONDROCYTES FROM OA PATIENTS

2014- Abella Cajigal, Vanesa; Gómez-Reino Carnota, Juan Jesús; Scotece, Morena; Gualillo ., Oreste; Pino Mínguez, Jesús; [et al.]

Adipokines induce inflammatory mediators in CD4DT cells and modulate the cross talk between CD4D T lymphocytes and chondrocytes from OA patients

2014- Gómez-Reino Carnota, Juan Jesús; Scotece, Morena; Gualillo ., Oreste; Pino Mínguez, Jesús; Conde Aranda, Javier; [et al.]

Adipokines, metabolic syndrome and rheumatic diseases

2014- Abella Cajigal, Vanesa; Scotece, Morena; Conde Aranda, Javier; López López, Verónica; Lazzaro, Veronica; [et al.]

Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity.

2011- Gómez-Reino Carnota, Juan Jesús; Lago Paz, Francisca; Scotece, Morena; Gualillo ., Oreste; Conde Aranda, Javier; [et al.]

Adipokines: novel players in rheumatic diseases

2013- Gómez-Reino Carnota, Juan Jesús; Lago Paz, Francisca; Scotece, Morena; Gualillo, Oreste; Pino Mínguez, Jesús; [et al.]

Adiponectin and leptin increase IL-8 production in human chondrocytes

2011- Gómez-Reino Carnota, Juan Jesús; Lago Paz, Francisca; Scotece, Morena; Gualillo ., Oreste; Conde Aranda, Javier; [et al.]

Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes

2012- Conde Aranda, Javier; Scotece, Morena; López López, Verónica; Gomez, R; Lago Paz, Francisca; [et al.]

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

2011- Gómez-Reino Carnota, Juan Jesús; Carmona Ortells, Loreto

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

2011- Gómez-Reino Carnota, Juan Jesús

An update on leptin as immunomodulator

2014- Abella Cajigal, Vanesa; Gómez-Reino Carnota, Juan Jesús; Scotece, Morena; Gualillo ., Oreste; Pino Mínguez, Jesús; [et al.]

Analysis of candidate osteoarthritis genes in a meta-analysis of 8 genome-wide association studies

2011- Calaza Cabanas, Manuel; Gómez-Reino Carnota, Juan Jesús; Rodríguez Fontenla, Cristina; González Ferro, Angela

Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

2014- Gómez-Reino Carnota, Juan Jesús

Antibodies against Carbamylated Proteins (ANTI-CARP), a new type of autoantibody, in spanish patients with rheumatoid arthritis

2014- Gómez-Reino Carnota, Juan Jesús; González Martínez-Pedrayo, Antonio; Montes Martínez, Ariana María; Pérez Pampín, Eva; Bóveda Fontán, María Dolores [et al.]

Repositorio digital RUNA

Navegar por autor "Gómez-Reino Carnota, Juan Jesús"

4.2-year results: Long-term efficacy of tocilizumab treatment for RA ﻿

A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone ﻿

Actualizacion 2014 del Documento de Consenso de la Sociedad Espanola de Reumatologia sobre el uso de terapias biologicas en la artritis reumatoide ﻿

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain ﻿

Adipokines and osteoarthritis: Novel molecules involved in the pathogenesis and progression of disease ﻿

Adipokines as biomarkers of rheumatic diseases ﻿

Adipokines as drug targets in joint and bone disease ﻿

ADIPOKINES INDUCE INFLAMMATORY MEDIATORS IN CD4+T CELLS AND MODULATE THE CROSS TALK BETWEEN CD4+T LYMPHOCYTES AND CHONDROCYTES FROM OA PATIENTS ﻿

Adipokines induce inflammatory mediators in CD4DT cells and modulate the cross talk between CD4D T lymphocytes and chondrocytes from OA patients ﻿

Adipokines, metabolic syndrome and rheumatic diseases ﻿

Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. ﻿

Adipokines: novel players in rheumatic diseases ﻿

Adiponectin and leptin increase IL-8 production in human chondrocytes ﻿

Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes ﻿

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry ﻿

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials ﻿

An update on leptin as immunomodulator ﻿

Analysis of candidate osteoarthritis genes in a meta-analysis of 8 genome-wide association studies ﻿

Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis ﻿

Antibodies against Carbamylated Proteins (ANTI-CARP), a new type of autoantibody, in spanish patients with rheumatoid arthritis ﻿

4.2-year results: Long-term efficacy of tocilizumab treatment for RA

A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

Actualizacion 2014 del Documento de Consenso de la Sociedad Espanola de Reumatologia sobre el uso de terapias biologicas en la artritis reumatoide

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain

Adipokines and osteoarthritis: Novel molecules involved in the pathogenesis and progression of disease

Adipokines as biomarkers of rheumatic diseases

Adipokines as drug targets in joint and bone disease

ADIPOKINES INDUCE INFLAMMATORY MEDIATORS IN CD4+T CELLS AND MODULATE THE CROSS TALK BETWEEN CD4+T LYMPHOCYTES AND CHONDROCYTES FROM OA PATIENTS

Adipokines induce inflammatory mediators in CD4DT cells and modulate the cross talk between CD4D T lymphocytes and chondrocytes from OA patients

Adipokines, metabolic syndrome and rheumatic diseases

Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity.

Adipokines: novel players in rheumatic diseases

Adiponectin and leptin increase IL-8 production in human chondrocytes

Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes

Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

An update on leptin as immunomodulator

Analysis of candidate osteoarthritis genes in a meta-analysis of 8 genome-wide association studies

Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

Antibodies against Carbamylated Proteins (ANTI-CARP), a new type of autoantibody, in spanish patients with rheumatoid arthritis